By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today said that it has listed certain of its liquid chromatography and mass spectrometers as Class I medical devices with the US Food and Drug Administration.

The instruments that were listed are the company's Infinity Series 1200 LC platforms and 6000 Series mass specs. Class I classification is for devices that pose the least risk to patients and Class I devices are the least regulated under FDA's three classifications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.